Mahmood Lab at the Brigham and Women’s Hospital aims to utilize machine learning, data fusion, and medical image analysis to develop streamlined workflows for objective diagnosis, prognosis, and biomarker discovery. We are interested in developing automated and objective mechanisms for reducing interobserver and intraobserver variability in cancer diagnosis using artificial intelligence as an assistive tool for pathologists. The lab also focuses on the development of new algorithms and methods to identify clinically relevant morphologic phenotypes and biomarkers associated with response to specific therapeutic agents. We develop multimodal fusion algorithms for combining information from multiple imaging modalities, familial and patient histories and multi-omics data to make more precise diagnostic, prognostic and therapeutic determinations. We are affiliated with the Harvard Data Science Initiative; the Harvard Bioinformatics and Integrative Genomics (BIG) program; the Cancer Data Science Program at the Dana-Farber Cancer Institute and the Cancer Program at the Broad Institute of Harvard and MIT.
Harvard News - How AI Can Help Diagnose Rare Diseases
Inside precision medicine - From Slide to Pixels
Harvard News - Heart Saving AI
Harvard News - Predicting Cancer’s Epicenter
Bioengineering Today - How to Train Your Radiology AI
Auntminnie.com - Cinematic rendering bolsters AI for depth estimation on endoscopy
New pre-print, TITAN - A multimodal whole slide foundation model for computational pathology. See pre-print, and download model.
HEST library and dataset accepted for publication at NeurIPS 2024. See code here and download data here.